Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London. As one of the largest independent clinical research organisations in the UK, Richmond Pharmacology has the expertise and equipment to adapt its London Bridge facility to administer vaccines for many residents in Southwark and the surrounding areas.  


Neil Coyle MP for Southwark and Old Borough outlines why this is important in his interview with BBC Politics London.


Richmond Pharmacology has been supporting the local community throughout the pandemic by providing rapid COVID tests to a local primary school, church, and synagogue. Assistance was also offered to staff at nearby businesses and hospitals when testing for the virus was not easily accessible.


Keith Berelowitz, Director of Operations at Richmond Pharmacology, said: “At what could be a pivotal moment during this pandemic, we must all do what we can to expedite the rollout of the vaccine in our local communities. We recognise that Richmond Pharmacology has the skills and facilities to support the Government in ensuring that the most vulnerable in our society are protected as soon as possible.”


Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event